Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1985 Jan;53(1):81–88. doi: 10.1128/jvi.53.1.81-88.1985

Use of a bacterial expression vector to map the varicella-zoster virus major glycoprotein gene, gC.

R W Ellis, P M Keller, R S Lowe, R A Zivin
PMCID: PMC254981  PMID: 2981365

Abstract

The genome of varicella-zoster virus (VZV) encodes at least three major glycoprotein genes. Among viral gene products, the gC gene products are the most abundant glycoproteins and induce a substantial humoral immune response (Keller et al., J. Virol. 52:293-297, 1984). We utilized two independent approaches to map the gC gene. Small fragments of randomly digested VZV DNA were inserted into a bacterial expression vector. Bacterial colonies transformed by this vector library were screened serologically for antigen expression with monoclonal antibodies to gC. Hybridization of the plasmid DNA from a gC antigen-positive clone revealed homology to the 3' end of the VZV Us segment. In addition, mRNA from VZV-infected cells was hybrid selected by a set of VZV DNA recombinant plasmids and translated in vitro, and polypeptide products were immunoprecipitated by convalescent zoster serum or by monoclonal antibodies to gC. This analysis revealed that the mRNA encoding a 70,000-dalton polypeptide precipitable by anti-gC antibodies mapped to the HindIII C fragment, which circumscribes the entire Us region. We conclude that the VZV gC glycoprotein gene maps to the 3' end of the Us region and is expressed as a 70,000-dalton primary translational product. These results are consistent with the recently reported DNA sequence of Us (A.J. Davison, EMBO J. 2:2203-2209, 1983). Furthermore, glycosylation appears not to be required for a predominant portion of the antigenicity of gC glycoproteins. We also report the tentative map assignments for eight other VZV primary translational products.

Full text

PDF
81

Images in this article

84Image
on p.84
84Image
on p.84
85Image
on p.85
86Image
on p.86

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson S. Shotgun DNA sequencing using cloned DNase I-generated fragments. Nucleic Acids Res. 1981 Jul 10;9(13):3015–3027. doi: 10.1093/nar/9.13.3015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arbeter A. M., Starr S. E., Weibel R. E., Neff B. J., Plotkin S. A. Live attenuated varicella vaccine: the KMcC strain in healthy children. Pediatrics. 1983 Mar;71(3):307–312. [PubMed] [Google Scholar]
  3. Brunell P. A., Shehab Z., Geiser C., Waugh J. E. Administration of live varicella vaccine to children wtih leukaemia. Lancet. 1982 Nov 13;2(8307):1069–1073. doi: 10.1016/s0140-6736(82)90006-x. [DOI] [PubMed] [Google Scholar]
  4. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  5. Cooper J. A., Wittek R., Moss B. Hybridization selection and cell-free translation of mRNA's encoded within the inverted terminal repetition of the vaccinia virus genome. J Virol. 1981 Jan;37(1):284–294. doi: 10.1128/jvi.37.1.284-294.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Davison A. J. DNA sequence of the US component of the varicella-zoster virus genome. EMBO J. 1983;2(12):2203–2209. doi: 10.1002/j.1460-2075.1983.tb01724.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Davison A. J., Scott J. E. Molecular cloning of the varicella-zoster virus genome and derivation of six restriction endonuclease maps. J Gen Virol. 1983 Aug;64(Pt 8):1811–1814. doi: 10.1099/0022-1317-64-8-1811. [DOI] [PubMed] [Google Scholar]
  8. Dumas A. M., Geelen J. L., Weststrate M. W., Wertheim P., van der Noordaa J. XbaI, PstI, and BglII restriction enzyme maps of the two orientations of the varicella-zoster virus genome. J Virol. 1981 Aug;39(2):390–400. doi: 10.1128/jvi.39.2.390-400.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ecker J. R., Hyman R. W. Varicella zoster virus DNA exists as two isomers. Proc Natl Acad Sci U S A. 1982 Jan;79(1):156–160. doi: 10.1073/pnas.79.1.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Forghani B., Schmidt N. J., Myoraku C. K., Gallo D. Serological reactivity of some monoclonal antibodies to varicella-zoster virus. Arch Virol. 1982;73(3-4):311–317. doi: 10.1007/BF01318084. [DOI] [PubMed] [Google Scholar]
  11. Grose C., Edwards D. P., Friedrichs W. E., Weigle K. A., McGuire W. L. Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Infect Immun. 1983 Apr;40(1):381–388. doi: 10.1128/iai.40.1.381-388.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Grose C. The synthesis of glycoproteins in human melanoma cells infected with varicella-zoster virus. Virology. 1980 Feb;101(1):1–9. doi: 10.1016/0042-6822(80)90478-x. [DOI] [PubMed] [Google Scholar]
  13. Grose C. Zoster in children with cancer: radioimmune precipitation profiles of sera before and after illness. J Infect Dis. 1983 Jan;147(1):47–56. doi: 10.1093/infdis/147.1.47. [DOI] [PubMed] [Google Scholar]
  14. Helfman D. M., Feramisco J. R., Fiddes J. C., Thomas G. P., Hughes S. H. Identification of clones that encode chicken tropomyosin by direct immunological screening of a cDNA expression library. Proc Natl Acad Sci U S A. 1983 Jan;80(1):31–35. doi: 10.1073/pnas.80.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Keller P. M., Neff B. J., Ellis R. W. Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. J Virol. 1984 Oct;52(1):293–297. doi: 10.1128/jvi.52.1.293-297.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lee G. T., Para M. F., Spear P. G. Location of the structural genes for glycoproteins gD and gE and for other polypeptides in the S component of herpes simplex virus type 1 DNA. J Virol. 1982 Jul;43(1):41–49. doi: 10.1128/jvi.43.1.41-49.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Maxam A. M., Gilbert W. A new method for sequencing DNA. Proc Natl Acad Sci U S A. 1977 Feb;74(2):560–564. doi: 10.1073/pnas.74.2.560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Neff B. J., Weibel R. E., Villarejos V. M., Buynak E. B., McLean A. A., Morton D. H., Wolanski B. S., Hilleman M. R. Clinical and laboratory studies of KMcC strain live attenuated varicella virus. Proc Soc Exp Biol Med. 1981 Mar;166(3):339–347. doi: 10.3181/00379727-166-41071. [DOI] [PubMed] [Google Scholar]
  19. Shemer Y., Leventon-Kriss S., Sarov I. Isolation and polypeptide characterization of varicella-zoster virus. Virology. 1980 Oct 15;106(1):133–140. doi: 10.1016/0042-6822(80)90228-7. [DOI] [PubMed] [Google Scholar]
  20. Shiraki K., Okuno T., Yamanishi K., Takahashi M. Polypeptides of varicella-zoster virus (VZV) and immunological relationship of VZV and herpes simplex virus (HSV). J Gen Virol. 1982 Aug;61(Pt 2):255–269. doi: 10.1099/0022-1317-61-2-255. [DOI] [PubMed] [Google Scholar]
  21. Silhavy T. J., Benson S. A., Emr S. D. Mechanisms of protein localization. Microbiol Rev. 1983 Sep;47(3):313–344. doi: 10.1128/mr.47.3.313-344.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Straus S. E., Aulakh H. S., Ruyechan W. T., Hay J., Casey T. A., Vande Woude G. F., Owens J., Smith H. A. Structure of varicella-zoster virus DNA. J Virol. 1981 Nov;40(2):516–525. doi: 10.1128/jvi.40.2.516-525.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Straus S. E., Owens J., Ruyechan W. T., Takiff H. E., Casey T. A., Vande Woude G. F., Hay J. Molecular cloning and physical mapping of varicella-zoster virus DNA. Proc Natl Acad Sci U S A. 1982 Feb;79(4):993–997. doi: 10.1073/pnas.79.4.993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Takahashi M., Okuno Y., Otsuka T., Osame J., Takamizawa A. Development of a live attenuated varicella vaccine. Biken J. 1975 Mar;18(1):25–33. [PubMed] [Google Scholar]
  25. Weinstock G. M., ap Rhys C., Berman M. L., Hampar B., Jackson D., Silhavy T. J., Weisemann J., Zweig M. Open reading frame expression vectors: a general method for antigen production in Escherichia coli using protein fusions to beta-galactosidase. Proc Natl Acad Sci U S A. 1983 Jul;80(14):4432–4436. doi: 10.1073/pnas.80.14.4432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Weis J. H., Enquist L. W., Salstrom J. S., Watson R. J. An immunologically active chimaeric protein containing herpes simplex virus type 1 glycoprotein D. Nature. 1983 Mar 3;302(5903):72–74. doi: 10.1038/302072a0. [DOI] [PubMed] [Google Scholar]
  27. Zweerink H. J., Neff B. J. Immune response after exposure to varicella zoster virus: characterization of virus-specific antibodies and their corresponding antigens. Infect Immun. 1981 Jan;31(1):436–444. doi: 10.1128/iai.31.1.436-444.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES